Neurofibroma historical perspective: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) |
Sara Mohsin (talk | contribs) |
||
Line 5: | Line 5: | ||
==Classification== | ==Classification== | ||
*In 2006, Yang et al demonstrated a critical neurofibroma microenvironment interaction that SCF-stimulated Nf1+/− mast cells potentiate Nf1+/− fibroblast functions. | |||
==References== | ==References== |
Revision as of 13:45, 28 March 2019
Neurofibroma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Neurofibroma historical perspective On the Web |
American Roentgen Ray Society Images of Neurofibroma historical perspective |
Risk calculators and risk factors for Neurofibroma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]
Overview
Classification
- In 2006, Yang et al demonstrated a critical neurofibroma microenvironment interaction that SCF-stimulated Nf1+/− mast cells potentiate Nf1+/− fibroblast functions.